Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [24]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-801-007-C250 - Provider product page
- Provider
- Enzo Life Sciences
- Product name
- MRP1 monoclonal antibody (MRPr1)
- Antibody type
- Monoclonal
- Antigen
- Recombinant protein fragment
- Reactivity
- Human, Mouse
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- MRPr1
- Vial size
- 250 μg
- Storage
- -20°C
Submitted references Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.
Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region.
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites.
The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells.
Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1).
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer.
Tissue distribution of the multidrug resistance protein.
Multidrug resistance-associated protein expression in clinical gastric carcinoma.
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Membrane transport proteins associated with drug resistance expressed in human melanoma.
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies.
Tivnan A, Zakaria Z, O'Leary C, Kögel D, Pokorny JL, Sarkaria JN, Prehn JH
Frontiers in neuroscience 2015;9:218
Frontiers in neuroscience 2015;9:218
Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region.
Westlake CJ, Payen L, Gao M, Cole SP, Deeley RG
The Journal of biological chemistry 2004 Dec 17;279(51):53571-83
The Journal of biological chemistry 2004 Dec 17;279(51):53571-83
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, van der Linden M, de Vree JM, van der Valk P, Elferink RP, Borst P, Scheper RJ
Cancer research 2000 Sep 15;60(18):5269-77
Cancer research 2000 Sep 15;60(18):5269-77
The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites.
Daoud R, Desneves J, Deady LW, Tilley L, Scheper RJ, Gros P, Georges E
Biochemistry 2000 May 23;39(20):6094-102
Biochemistry 2000 May 23;39(20):6094-102
The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells.
Prechtl S, Roellinghoff M, Scheper R, Cole SP, Deeley RG, Lohoff M
Journal of immunology (Baltimore, Md. : 1950) 2000 Jan 15;164(2):754-61
Journal of immunology (Baltimore, Md. : 1950) 2000 Jan 15;164(2):754-61
Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1).
Daoud R, Kast C, Gros P, Georges E
Biochemistry 2000 Dec 19;39(50):15344-52
Biochemistry 2000 Dec 19;39(50):15344-52
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M, Turzanski J, Langabeer S, Russell NH
Advances in experimental medicine and biology 1999;457:77-88
Advances in experimental medicine and biology 1999;457:77-88
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ, Katsaros D, de Vries EG, Massobrio M, Genta F, Danese S, Arisio R, Scheper RJ, Kool M, Scheffer GL, Willemse PH, van der Zee AG, Suurmeijer AJ
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Oct;5(10):2798-805
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Oct;5(10):2798-805
Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W
Leukemia 1999 Nov;13(11):1864-72
Leukemia 1999 Nov;13(11):1864-72
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica-Worms D
Proceedings of the National Academy of Sciences of the United States of America 1999 Mar 30;96(7):3900-5
Proceedings of the National Academy of Sciences of the United States of America 1999 Mar 30;96(7):3900-5
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
Meijer GA, Schroeijers AB, Flens MJ, Meuwissen SG, van der Valk P, Baak JP, Scheper RJ
Journal of clinical pathology 1999 Jun;52(6):450-4
Journal of clinical pathology 1999 Jun;52(6):450-4
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).
Hipfner DR, Gao M, Scheffer G, Scheper RJ, Deeley RG, Cole SP
British journal of cancer 1998 Nov;78(9):1134-40
British journal of cancer 1998 Nov;78(9):1134-40
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ
Blood 1998 Mar 15;91(6):2092-8
Blood 1998 Mar 15;91(6):2092-8
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
Nooter K, Brutel de la Riviere G, Look MP, van Wingerden KE, Henzen-Logmans SC, Scheper RJ, Flens MJ, Klijn JG, Stoter G, Foekens JA
British journal of cancer 1997;76(4):486-93
British journal of cancer 1997;76(4):486-93
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Den Boer ML, Zwaan CM, Pieters R, Kazemier KM, Rottier MM, Flens MJ, Scheper RJ, Veerman AJ
Leukemia 1997 Jul;11(7):1078-85
Leukemia 1997 Jul;11(7):1078-85
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R
Cancer research 1996 Jul 1;56(13):3010-20
Cancer research 1996 Jul 1;56(13):3010-20
Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer.
Nooter K, Bosman FT, Burger H, van Wingerden KE, Flens MJ, Scheper RJ, Oostrum RG, Boersma AW, van der Gaast A, Stoter G
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996 Jan;7(1):75-81
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996 Jan;7(1):75-81
Tissue distribution of the multidrug resistance protein.
Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, de Haas M, Meijer CJ, Scheper RJ
The American journal of pathology 1996 Apr;148(4):1237-47
The American journal of pathology 1996 Apr;148(4):1237-47
Multidrug resistance-associated protein expression in clinical gastric carcinoma.
Endo K, Maehara Y, Ichiyoshi Y, Kusumoto T, Sakaguchi Y, Ohno S, Sugimachi K
Cancer 1996 Apr 15;77(8 Suppl):1681-7
Cancer 1996 Apr 15;77(8 Suppl):1681-7
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Nooter K, Westerman AM, Flens MJ, Zaman GJ, Scheper RJ, van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P
Clinical cancer research : an official journal of the American Association for Cancer Research 1995 Nov;1(11):1301-10
Clinical cancer research : an official journal of the American Association for Cancer Research 1995 Nov;1(11):1301-10
Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf D, Makki A, Stahr C, van Dyck A, Wanner R, Scheffer GL, Flens MJ, Scheper R, Henz BM
The American journal of pathology 1995 Dec;147(6):1545-52
The American journal of pathology 1995 Dec;147(6):1545-52
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ
Proceedings of the National Academy of Sciences of the United States of America 1994 Sep 13;91(19):8822-6
Proceedings of the National Academy of Sciences of the United States of America 1994 Sep 13;91(19):8822-6
Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Scheper RJ, Zaman GJ
Cancer research 1994 Sep 1;54(17):4557-63
Cancer research 1994 Sep 1;54(17):4557-63
Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies.
Hipfner DR, Gauldie SD, Deeley RG, Cole SP
Cancer research 1994 Nov 15;54(22):5788-92
Cancer research 1994 Nov 15;54(22):5788-92
No comments: Submit comment
No validations: Submit validation data